LibertinyGHandsL. Lower limb deep venous flow in patients with peripheral vascular disease. J Vasc Surg1999;29:1065-1070.
6.
GradyDWengerNKHerringtonD, et al.Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The heart and estrogen/progestin replacement study. Ann Intern Med2000;132:689-696.
7.
StoneNJ. Statins in secondary prevention. J Am Coll Cardiol2017;69:2707-2709.
8.
LeeningMJG. Who benefits from taking a statin, and when?Circulation2020;142:838-840.
9.
RodriguezALWojcikBMWrobleskiSKMyersDDJrWakefieldTWDiazJA. Statins, inflammation and deep vein thrombosis: a systematic review. J Thromb Thrombolysis2012;33:371-382.
10.
LinMSChungCMChenMY, et al.Venous thromboembolism and critical limb events in patients with atrial fibrillation: a nationwide population-based cohort study. Angiology2022;73:413-421.
11.
LinLYWarren-GashCSmeethL, et al.Data resource profile: the national health insurance research database (NHIRD). Epidemiol Health2018;40:e2018062.
12.
HsiehCYSuCCShaoSC, et al.Taiwan’s national health insurance research database: past and future. Clin Epidemiol2019;11:349–358.
13.
ShariffNAleemASinghMZ LiYJ SmithS. AF and venous thromboembolism-pathophysiology, risk assessment and CHADS-VASc score. J Atr Fibrillation2012;5:649.